XAMS
ASRNL
Market cap16bUSD
Oct 20, Last price
74.08EUR
1D
0.54%
1Q
4.84%
Jan 2017
227.79%
IPO
277.00%
Name
ASR Nederland NV
Chart & performance
P/E
25.71
P/B
2.37
EPS
2.88
Vol. 1Y
15.97%
Shs. 5Y
5.15%
Rev. 5Y
23.10%
Div Yld LY
4.36%
Div Yld TTM
4.77%
Revenues
21.23b
+2.88%
Net income
582m
-34.09%
CFO
-569m
L-18.60%
Dividend
Aug 26, 20261.39 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ASR Nederland N.V. is a Dutch financial services provider that delivers a range of products including insurance coverage, pension plans, and mortgage solutions. It serves a broad customer base, encompassing individuals, independent professionals, and corporate clients. The company's business activities are structured across five distinct divisions: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. Beyond its core offerings, ASR Nederland is involved in distributing various insurance policies, furnishing financial intermediary assistance, and executing real estate development ventures. Additionally, it functions as an asset manager for external parties. The firm markets its products under several recognized brands, such as De Amersfoortse, Loyalis, Ditzo, Europeesche Verzekeringen, and Ardanta. Founded in 1720, the company operated as Fortis Verzekeringen Nederland N.V. until it rebranded as ASR Nederland N.V. in October 2008. Its headquarters are situated in Utrecht, the Netherlands.
Related entities
Subsidiaries (28)
Advies van a.s.r. B.V .
ASAM N.V.
ASR Administratieve Dienstverlening B.V.
ASR Deelnemingen N.V.
ASR DL B.V.
ASR Hypotheken B.V.
ASR Levensverzekering N.V.
ASR Premiepensioeninstelling N.V.
ASR Real Estate B.V.
ASR Schadeverzekering N.V.
ASR Service Maatschappij N.V.
ASR Spaarkas N.V.
ASR Vermogensbeheer N.V.
ASR Vooruit B.V.
ASR Ziektekostenverzekeringen N.V.
Nedasco B.V.
TKP Pensioen B.V.
ASR Aanvullende Ziektekostenverzekeringen N.V.
ASR Basis Ziektekostenverzekeringen N.V.
ASR Funding B.V.
Key people
Joannes Wijn
Independent Chairman of the Supervisory Board · since 2021
J.P.M. Baeten
Chairman of the Executive Board, Chief Executive Officer · since 2009
Ewout Hollegien
Chief Financial Officer, Member of the Executive Board · since 2021
Jolanda Sappelli
Chief Human Resources Officer, Member of the Management Board · since 2023
I.M.A. De Swart
Chief Operating Officer, Chief Technology Officer, Member of the Management Board, Member of the Executive Board · since 2019
Rozan Dekker
Chief Risk Officer, Member of the Management Board · since 2023
Willem van Den Berg
COO Life, Member of the Management Board · since 2023
Independent Member of the Supervisory Board · since 2024
D. Heijtmajer
Independent Member of the Supervisory Board · since 2023
G. van Olphen
Independent Member of the Supervisory Board · since 2019
S. Barendregt
Independent Member of the Supervisory Board · since 2018
G. Eikelenboom
Independent Member of the Supervisory Board · since 2019
E. Friese
Member of the Supervisory Board · since 2023
Headquarters & legal address
Archimedeslaan 10
Utrecht 3584BA
NL
Utrecht 3584BA
NL
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||